Home » NZ 'LAGGING BEHIND' IN DRUG RESEARCH
NZ 'LAGGING BEHIND' IN DRUG RESEARCH
Government "hostility" is forcing pharmaceutical companies to abandon research and development in New Zealand, costing the country up to $100 million in lost investment, according to a report released today.
The New Zealand Herald
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May